Deep-Track-Capital-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "AKRO",
  "EWTX",
  "INSM",
  "APLS",
  "ANIP",
  "ABVX",
  "GLPG",
  "DVAX",
  "NVAX",
  "BCAX",
  "BCYC",
  "OLMA",
  "GPCR",
  "RAPP",
  "TERN",
  "NRIX",
  "MNMD",
  "TECX",
  "NGNE",
  "SAGE",
  "ALGS",
  "ALLK",
  "AVTX",
  "GERN",
  "SYRE",
  "AUTL",
  "TARS",
  "GH",
  "IVVD",
  "KRRO",
  null,
  null,
  "OKUR",
  "SEPN",
  "IONS",
  "CYBN",
  "GHRS",
  "ZURA",
  "AMGN",
  "UPB",
  "RAPT",
  "PTGX",
  "MBX",
  "RGLS",
  "PLRX",
  "ETNB",
  "DYN",
  "SRPT",
  null,
  null,
  "CMPS",
  "CNTX",
  "IMCR",
  "IKNA",
  "INO",
  "VRDN",
  "XENE",
  "XNCR",
  "ORKA",
  null,
  "RARE",
  "IMVT",
  "PCVX",
  "BEAM",
  "BBIO",
  "CLDX",
  "CYTK",
  "DNTH"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 69
Total Value: 3088173822
Accession Number: 0001856083-25-000002
Form Type: 13F-HR
CIK: deep-track-capital-lp
Manager Name: Deep-Track-Capital-Lp

Data Enrichment

93% identified

64 identified5 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

69 positions • $3.1B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 4 of 4

Sort by:

Context Therapeutics Inc.

CNTX|21077P108

Shares:7.4M

Value:$4.5M

% of Portfolio:0.1% ($4.5M/$3.1B)

Zura Bio Ltd

ZURA|G9TY5A101

Shares:3.3M

Value:$4.2M

% of Portfolio:0.1% ($4.2M/$3.1B)

Aligos Therapeutics, Inc.

ALGS|01626L204

Shares:444.1K

Value:$3.7M

% of Portfolio:0.1% ($3.7M/$3.1B)

Spyre Therapeutics, Inc.

SYRE|00773J202

Shares:219.0K

Value:$3.5M

% of Portfolio:0.1% ($3.5M/$3.1B)

Ikena Oncology, Inc.

IKNA|45175G108

Shares:2.5M

Value:$3.2M

% of Portfolio:0.1% ($3.2M/$3.1B)

OnKure Therapeutics, Inc.

OKUR|68277Q105

Shares:524.0K

Value:$2.3M

% of Portfolio:0.1% ($2.3M/$3.1B)

Allakos Inc.

ALLK|01671P100

Shares:7.2M

Value:$1.6M

% of Portfolio:0.1% ($1.6M/$3.1B)

Neurogene Inc.

NGNE|64135M105

Shares:116.7K

Value:$1.4M

% of Portfolio:0.0% ($1.4M/$3.1B)

28658R106

Shares:1.0M

Value:$1.3M

% of Portfolio:0.0% ($1.3M/$3.1B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Context Therapeutics Inc.(CNTXcusip21077P108)	7.4M	QoQ 0.00% (-0) YoY NEW(+7.4M)	All Managers (Combined)	$4.5M	0.1% ($4.5M/$3.1B)	QoQ -41.71% (-$3.2M) YoY NEW(+$4.5M)
Zura Bio Ltd(ZURAcusipG9TY5A101)	3.3M	QoQ 0.00% (-0) YoY +30.15% (-760.8K)	All Managers (Combined)	$4.2M	0.1% ($4.2M/$3.1B)	QoQ -48.40% (-$4.0M) YoY -34.66% (-$2.2M)
Aligos Therapeutics, Inc.(ALGScusip01626L204)	444.1K	QoQ +81.93% (-200.0K) YoY NEW(+444.1K)	All Managers (Combined)	$3.7M	0.1% ($3.7M/$3.1B)	QoQ -62.32% (-$6.1M) YoY NEW(+$3.7M)
Spyre Therapeutics, Inc.(SYREcusip00773J202)	219.0K	QoQ 0.00% (-0) YoY -81.95% (-994.4K)	All Managers (Combined)	$3.5M	0.1% ($3.5M/$3.1B)	QoQ -30.69% (-$1.6M) YoY -92.32% (-$42.5M)
Ikena Oncology, Inc.(IKNAcusip45175G108)	2.5M	QoQ NEW(+2.5M) YoY NEW(+2.5M)	All Managers (Combined)	$3.2M	0.1% ($3.2M/$3.1B)	QoQ NEW(+$3.2M) YoY NEW(+$3.2M)
OnKure Therapeutics, Inc.(OKURcusip68277Q105)	524.0K	QoQ 0.00% (-0) YoY NEW(+524.0K)	All Managers (Combined)	$2.3M	0.1% ($2.3M/$3.1B)	QoQ -49.99% (-$2.3M) YoY NEW(+$2.3M)
Allakos Inc.(ALLKcusip01671P100)	7.2M	QoQ +26.79% (-1.5M) YoY +44.65% (-2.2M)	All Managers (Combined)	$1.6M	0.1% ($1.6M/$3.1B)	QoQ -76.15% (-$5.3M) YoY -73.87% (-$4.7M)
Neurogene Inc.(NGNEcusip64135M105)	116.7K	QoQ NEW(+116.7K) YoY NEW(+116.7K)	All Managers (Combined)	$1.4M	0.0% ($1.4M/$3.1B)	QoQ NEW(+$1.4M) YoY NEW(+$1.4M)
(cusip28658R106)✕	1.0M	QoQ 0.00% (-0) YoY NEW(+1.0M)	All Managers (Combined)	$1.3M	0.0% ($1.3M/$3.1B)	QoQ -32.22% (-$603.3K) YoY NEW(+$1.3M)